The use of high-throughput multiplexed screening platforms has attracted significant interest in the field of on-site disease detection and diagnostics for their capability to simultaneously interrogate single-cell responses across different populations. However, many of the current approaches are limited by the spectral overlap between tracking materials (e.g., organic dyes) and commonly used fluorophores/biochemical stains, thus restraining their applications in multiplexed studies. This work demonstrates that the downconversion emission spectra offered by rare earth (RE)-doped β-hexagonal NaYF 4 nanoparticles (NPs) can be exploited to address this spectral overlap issue. Compared to organic dyes and other tracking materials where the excitation and emission is separated by tens of nanometers, RE elements have a large gap between excitation and emission which results in their spectral independence from the organic dyes. As a proof of concept, two differently doped NaYF 4 NPs (europium: Eu -doped NPs with each other and with common fluorophores highlights the potential application of this novel technique in multiplexed systems, where many such luminescent NPs (other doped and co-doped NPs) can be used to simultaneously track different input conditions on the same platform.
Introduction
Isolating and analyzing single cells from a heterogeneous population is essential to perform clinically relevant measurements with respect to cancer diagnostics [1] [2] [3] . Droplet microfluidics has emerged as a single-cell sorting technology which offers several advantages over existing large-scale technologies like capillary electrophoresis, flow cytometry, and mass cytometry in terms of its reduced reagent costs, easeof-use, and compatibility with fluorescent microscopy [4, 5] . Fluorescence-activated cell sorting (FACS) is a commercialized flow cytometry technique, capable of simultaneous quantification up to 20 parameters in single cells based on specific light scattering and fluorescent characteristics of each cell (called fluorescent-cell barcoding) [6, 7] . However, flow cytometry is often limited by its need for large sample size, the Manibarathi Vaithiyanathan and Khashayar R. Bajgiran contributed equally to this work.
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The online version of this article (https://doi.org/10.1007/s00216-018-1448-1) contains supplementary material, which is available to authorized users. cost and size of the instrument, [8] , and the use of rapid flow in the system which, when coupled with non-specific surface markers, can negatively affect cell viability [9] . There have been reports on spectral crosstalk between these fluorescentcell barcodes which was addressed by mass cytometry, a method where each sample is labeled with a unique combination of lanthanide isotopes (called mass-tag barcoding) [6, 10] . Despite having a lower throughput than flow cytometry [4] , the spectrally distinct mass-tag barcodes in mass cytometry make it an ideal system for multiplex studies [6] . However, mass cytometry is limited by its inability to sort cells during analysis coupled with a poor signal-to-noise ratio [11] .
The high-throughput screening (HTS) technologies discussed above offer extensive information on single-cell analysis but are restrained in their ability to directly quantify the intracellular distribution of fluorescent signals. Droplet microfluidic devices enabled with spatial traps [12, 13] have recently found applications in dynamic applications like single-cell barcoding and sequencing [14, 15] (barcoding here means indexing or tracking something in a microfluidic device by giving an identity-either track a droplet/cell/molecule using some technique). One such example is to isolate and amplify single DNA molecules within droplets and barcode each of these droplets using chemically synthesized oligonucleotides [16] . Another such droplet-based technique is inDrops (indexing droplets) where cells are indexed by hydrogel beads bearing DNA primer barcodes for single-cell RNA sequencing [17] . While these microfluidic devices have emerged as powerful tools in profiling cellular heterogeneity, they make use of expensive barcoding antibodies and involve time-consuming reactions. Other droplet barcoding techniques utilizing organic dyes [18, 19] are also limited in their ability to simultaneously quantify different cellular outputs due to the spectral overlap of these dyes with common biochemical stains [20] [21] [22] . These issues have resulted in some limitations in the use of droplet microfluidics in multiplexed applications where simultaneous tracking of cellular outputs to different input conditions on a single platform is required.
Advances in nanomaterials have produced a new class of fluorescent labels by conjugating semiconductor quantum dots (QDs) with biorecognition molecules [23] [24] [25] . Because of their size-tuneable absorptions/emissions, and high fluorescence quantum yield, QDs are considered a better alternative to organic dyes [21, 22] . Although being widely used as fluorescent barcodes in platforms such as FACS [26, 27] and droplet microfluidics [28] , there have been concerns regarding QDs' cytotoxicity, with heavy metals being used in their crystal structure [29] . Rare earth (RE)-doped materials are a class of phosphors that have received attention for their potential applications in bio-imaging, sensing, and therapeutics [30] . Unlike organic dyes and common fluorophores, RE dopants offer a wide range of characteristic emission lines in the visible spectrum stemming from the f-f intraband transitions, ) making them suitable as spectrally independent labels [30] . Additionally, the large gap between excitations and emissions of the RE elements serves as an added advantage for spectral independence when compared to the closer excitations and emissions of organic dyes [30, 31] . Also, RE phosphors have been shown to exhibit greater biocompatibility over QDs [32] . Two RE luminescence mechanisms are possible, downconversion (DC) and upconversion (UC), which are analogous to Stokes and anti-Stokes shift, respectively. In UC materials, luminescence occurs by sequential absorption of lower energy photons followed by a higher energy emission. UC phosphors have been extensively exploited for in vivo bio-imaging, photodynamic therapy, and drug delivery, primarily due to their minimal photodamage to living organisms and excitation within the biologically transparent window [33] . On the other hand, the unexplored, diverse energy levels available with DC make these elements suitable for multiplex tracking purposes for in vitro studies. The DC process stems from the unique optoelectronic properties of the RE ions in which higher energy photons such as UV radiation is converted to lower energy visible light, resulting in narrow and spectrally independent emission peaks that is suitable for tracking purposes in biological studies [34] .
This work describes the use of spectrally independent REdoped nanoparticles (NPs) as droplet trackers using DC luminescence imaged by fluorescent microscopy. The synthesized RE-doped β-NaYF 4 NPs were successfully characterized for structure, morphology, spectral properties, and biocompatibility. Europium (Eu
3+
) and terbium (Tb 3+ ) were chosen as RE dopants to track droplets due to their narrow, but spectrally independent, emission peaks. A series of single-cell and NP co-encapsulation studies were performed in a microfluidic droplet trapping array to confirm the spectral independence of Eu 3+ -doped and Tb 3+ -doped NPs with green fluorescent protein (GFP), red fluorescent protein (RFP), and ethidium homodimer-1 (EthD-1). In terms of broad comparison, GFP and RFP are the two main fluorescent labels used in biological purposes. While many variants (e.g., FAM, Alexa Fluor, Texas Red, Rhodamine) are used due to sensitivity and ease of conjugation, all these fluorescent probes have similar excitation/emission range as that of GFP and RFP [35] . Upon UV excitation, the RE dopants in NPs exhibited unique emission peaks (Eu 3+ -doped NP in red and Tb
-doped NP in green) that did not overlap with commonly used fluorophores. While this work demonstrates the feasibility of two RE-doped NPs, this tracking technique can be expanded with several different doped and co-doped NPs [30] , thus implementing the diversity of downconversion luminescence in multiplexed screening. The results from this study confirm the potential for luminescent NPs as droplet trackers and provide a justification for their use in a multiplexed device, thus highlighting the successful first ever use of these NPs as spectrally independent droplet trackers on a fluorescent microscopy stage.
Experimental

Synthesis and characterization of RE-doped luminescent NPs
A simple one-step hydrothermal process was implemented to synthesize NaYF 4 ) was used for the doped samples. The solution was then transferred to a 20-mL Teflon liner containing 15 mL of DI H 2 O. Next, 8 mmol of Na 3 citrate (ACS grade, VWR) (RE precursors: Na 3 citrate = 1:4) was added to the above mixture as a chelating agent to control the size and morphology of the NPs. After 30 min of vigorous stirring, 5 mL of a 5 M NaF (USP grade, VWR) aqueous solution was added to the precursor solution as a fluoride source. The contents were thoroughly mixed for 15 min. The Teflon liner was transferred into an autoclave for subsequent heating at 180°C for 1 h. The products were then collected and washed with DI H 2 O and EtOH (ACS grade, VWR) several times to remove the organic impurities and neutralize the solution. Finally, the samples were dried at 100°C, and the NPs were annealed at 400°C for 2 h to ensure successful incorporation of dopants to their respective crystal sites.
The synthesized NPs were characterized for their structure, size, morphology, and composition using X-ray diffraction spectroscopy (XRD), scanning electron microscopy (SEM), and energy dispersive X-ray spectroscopy (EDX or EDS). XRD measurements were performed on an Empyrean PANalytical X-ray diffractometer using Cu K α1 (λ = 1.54 Å) as radiation source, with a step size of 0.05°in the scanning range of 5°-70°. SEM imaging was done using an FEI Quanta 3D FIB microscope operated at 5-kV accelerating voltage. This instrument was equipped with an EDAX detector which was used to identify the elements present in the sample. The sample was prepared by casting a drop of the aqueous product on the double-sided carbon tape attached to the sample holder. All the dried samples were sputtered with Pt for 4 min to make the sample conductive for measurements. The NP luminescence was characterized using a photoluminescence (PL) spectrometer. An APTI QM-40 spectrofluorometer with a PMT detector and a 75-W xenon arc lamp as light source was employed for PL measurements. The scans were performed with a band pass of 2 nm at a scanning rate of 4 nm/s in the range of 400-700 nm.
Microfluidic device design and fabrication
The droplet microfluidic trapping device consisted of two layers ( Fig. 1) : the bottom main flow channel and the top trapping array. The device had two inlet channels: one for the oil phase (230 μL/h) and one for the aqueous phase (90 μL/h) which converged at a flow-focusing junction to encapsulate cells and NPs in~180 pL discrete aqueous droplets in a continuous oil phase. The oil phase was Novec 7500 oil (3 M) with 0.2% Neat 008 fluorosurfactant (Ran Biotechnologies). The fluorosurfactant was used to stabilize droplet formation and prevent droplet aggregation. Vertical fins were incorporated into the bottom layer of the trapping array to increase the residence time of the droplets and aid in trapping. The trapping array consisted of a 787-member grid with each trap having a 70-μm diameter. The fluidic channels were 40 μm in height and the traps were imprinted 40 μm into the polydimethylsiloxane (PDMS) above the fluidic channel (total of 80 μm in height). The methods for PDMS replication and device preparation are included in the Supporting Information. The resultant devices were used for on-chip encapsulation experiments. To initiate droplet generation, Tygon tubing (Cole Palmer) was directly connected to oil and aqueous syringes fixed on two dual infusion syringe pumps (Harvard apparatus) and was inserted into the device inlet ports. The device was mounted on the stage of a fluorescent DMi8 inverted microscope (Leica Microsystems) to visualize droplet formation and trapping. 
Cell culture
Off-chip viability assay
MDA-MB-231 cells were seeded at a density of 1 × 10 4 cells/ mL in 12-well plates and incubated for 3 days. On the day of experiment, each well (in duplicate) was subjected to the viability assay at time points of 0 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, and 12 h. Each pair of wells was washed with 1 mL of 1X PBS (PBS, 137 mM NaCl; 10 mM Na 2 HPO 4 ; 27 mM KCl; and 1.75 mM KH 2 PO 4 at pH 7.4) followed by the addition of 1 mL of a 10-mg/mL NP slurry in extracellular buffer (ECB, 20 mM HEPES; 140 mM NaCl; 5 mM KCl; 1 mM MgCl 2 ·6H 2 O; 1 mM CaCl 2 ·2H 2 O; 5 mM D-glucose at pH 7.4) with 1% FBS at specified time points over 12 h. After 12 h, the NP slurry was aspirated. After aspiration of NP slurry, the cells were not washed to avoid removal of any dead cells. Five hundred microliters of a reagent stain mixture (2.5 μM Calcein AM and 4 μM EthD-1 in 1X PBS) was added to each well and incubated for 15-20 min followed by imaging for viability. This assay was performed only with 10 mg/mL NP slurry since this was the maximum concentration used for all on-chip encapsulation experiments and the results obtained for any lower NP concentrations are inclusive of those obtained from the 10 mg/mL study.
Microfluidic droplet tracking using RE-doped NPs
A 10 mg/mL slurry of NPs in ECB was used for on-chip encapsulation experiments. In order to prevent particle aggregation and settling, the slurry was sonicated for 1 h before each experiment. The RE-doped NPs were co-encapsulated with cells (GFP-HeLa cells, RFP-MDA-MB-231 cells, and MDA-MB-231 cells stained with EthD-1 at a cell density of 4.5 × 10 6 cells/mL) in ECB droplets which were isolated in the microfluidic droplet trapping array. For EthD-1 biochemical staining, MDA-MB-231 cells were binned into two groups. The first group (live) was resuspended in ECB and incubated at 37°C prior to encapsulation. The second group (dead) was incubated at 42°C for 1 h [36] in a heat block to kill all the cells. The live and dead cells were mixed into a heterogeneous population and incubated with 2 μM EthD-1 at 37°C for 15-20 min off-chip prior to injection into the device along with the NP slurry. A fluorescent DMi8 inverted microscope (Leica microsystems) with a digital CMOS camera C11440 (Hamamatsu Photonics K.K.) and LAS X software 3. 
Equation (1) was used to calculate normalized fluorescent signal (NFS) where X is the fluorescent signal, μ is the mean fluorescent signal, and σ is the standard deviation. The NFS values were compared with noise to give S:N ratio values. These S:N ratio values were further analyzed for statistical significance through single/two-tailed hypotheses tests using SAS software.
On-chip dose-response studies MDA-MB-231 cells were initially seeded at a density of 4.5 × 10 6 cells/mL in sterile 100 mm × 20 mm cell culture dishes. The cells were allowed to adhere and spread in the first 24 h. After 24 h, the media in each dish was swapped with 3 mL of drugged media. Three different concentrations of paclitaxel (PTX) were tested with MDA-MB-231 cells: 10 μM, 50 μM, and 100 μM. An off-chip drug treatment protocol was followed where each dish was treated with one of the three drug concentrations and the cellular response was later observed on-chip after 24 h, 48 h, or 72 h incubation. On the day of on-chip analysis, the cells were scraped from the surface of the culture dish using a sterile cell lifter (Corning) and transferred to a 15 mL tube. It is to be noted that no aspiration and centrifugation steps were included at this point, to avoid loss of floating dead cells after respective drug treatments. The cells were incubated with 2 μM EthD-1 at 37°C for 20 min prior to on-chip encapsulation. Before injecting the sample into the device, 10 mg/mL of NP slurry in DMEM was added to the existing 3 mL of stained cell sample. This cell and NP slurry was injected into the microfluidic device and imaged for the single-cell response across the trapping array. Three different NPs were used for the three different drug concentrations: Eu
3+
-doped NPs for 10 μM PTX, Tb
-doped NPs for 50 μM PTX, and undoped NPs for 100 μM PTX. No-drug control experiments were conducted in tandem for data validation. After each experiment, cellular viability and droplet tracking data was collected by imaging the trapping array using the fluorescent DMi8 inverted microscope and fluorescent filters rhodamine, filter set 1, and filter set 2.
Results and discussion
Synthesis and characterization of hexagonal β-NaYF 4 NPs for DC applications As previously reported [37, 38] , β-NaYF 4 crystal is frequently employed for optoelectronic applications due to its low phonon energy, and high local crystal asymmetry that results in stark splitting of energy levels, leading to efficient luminescence. The formation of hexagonal β-NaYF 4 crystal structures is dependent on several parameters such as citrate concentration, pH of the solution, annealing temperature, and reaction time [33, 39] . The SEM image of the synthesized particles is shown in Fig. 2a which verifies the monodisperse formation of sub-micron-sized hexagonal NaYF 4 particles. The average diameter and length of the NPs were 180 nm and 310 nm, respectively. The crystal phase of NaYF 4 was identified from XRD patterns (Fig. 2b) and indexed to standard β-NaYF 4 (JCPS 17-6069), indicating that no other impurity phase was formed. Particle composition was verified with elemental analysis (EDX- Fig. 2c ). Characteristic K α lines for Na, Y, and F along with characteristic L α and L β for Eu 3+ and Tb 3+ were identified. Due to low doping concentrations, EDX measurements for Eu 3+ and Tb 3+ were scaled by the factor of 10, illustrating the presence of each dopant in the crystal lattice. In order to be consistent with the characteristic properties of the NPs synthesized from different batches, the abovementioned steps were repeated to ensure batch-tobatch reproducibility of the synthesized NPs. This verified the chemical stability of NaYF 4 NPs which has been previously discussed elsewhere [40] . Room-temperature DC luminescence excitation and emission spectra of β-NaYF 4 :RE ) regions of visible light. It is noteworthy that the absorption and excitation profile of these RE elements are similar, as previously reported [41] . For fluorescent microscopy, a 605-645-nm window filter set was chosen to detect the 5 Once the nanoparticles were successfully synthesized and characterized, their biocompatibility was verified to quantify the effect of droplet tracking on cell viability, since experiments involved UV excitation of the NPs and peripheral -doped NaYF 4 NPs demonstrate the characteristic Eu 3+ and Tb 3+ emission peaks when excited with 395-nm and 350-nm light cell-NP interactions. UV initiated cellular/genetic damage was ruled in this application since a very low-dose, near UV excitation was used for both the NPs (800 ms of 395-nm exposure for Eu 3+ -NP and 800 ms of 330-nm exposure for Tb 3+ -NP). This has been reported previously where the effect of UV exposure times, up to 5 min, did not statistically affect the cell survival rate or did not alter their genetic expression [42, 43] . Secondly, the bio-inertness of NPs was verified in order to validate their use with cells for on-chip studies via an off-chip viability assay using a model breast cancer cell line, MDA-MB-231 (Fig. 3) Fig. S1A ) with ã 99% viability (586 of 595 cells). These results were compared to a no-NP control experiments (see ESM Fig. S1B ) which confirmed that the RE-doped NPs were biologically inert to the cells. This is in agreement with previous studies on biocompatibility of rare earth-based NPs [44] , demonstrating a clear advantage of these RE-doped NPs over quantum dots (QDs) [29] . It is to be noted here that, in this work, the luminescent NPs are only used for cellular tracking and that the large average diameter and length of the NPs (180 nm and 310 nm) restrict them from traversing across the cell membrane [45] .
Co-encapsulation of RE-doped NPs and single cells in microfluidic trapping array
Once it was confirmed that the RE-doped NPs were biocompatible, the next step was to assess their ability to be used as droplet trackers in the microfluidic droplet trapping array. Stable droplets containing Eu 3+ -doped (Fig. 4a) and Tb 3+ -doped (Fig. 4b) NPs were generated and trapped in the microfluidic device. A prominent signal was observed from the NPs using their respective filters by fluorescent microscopy which demonstrated the feasibility of utilizing these phosphors in a droplet microfluidic platform. The luminescent nanoparticles were then tested for spectral independence with commonly used fluorophores.
The majority of fluorescent probes derived from fluorescein, rhodamine, cyanine, boron-dipyrromethene (BODIPY), acridine, xanthene, and coumarin have green and red emission chromophores [35] . Fluorophores that emit in the green and red have several advantages in terms of high excitation coefficients and high fluorescent quantum yield [35, 46] , thus making the two colors preferable. Hence, in this work, green and red fluorophores (green fluorescent protein (GFP) and red fluorescent protein (RFP)) and red emitting viability stain (EthD-1) were tested as an example to highlight the utility of this tracking platform. Eu (Fig. 5a) . A similar experiment was performed with RFP-expressing MDA-MB-231 (emission peak centered at 588 nm). Although the selected Eu 3+ emission peaks fell within the range of rhodamine filter collecting the RFP signal (λ em = 545-625 nm), no Eu 3+ signal was detected in this filter (see ESM Fig. S2 ). This is due to the fact that the excitation wavelength of rhodamine filter (λ ex 536-556 nm) is outside of the Eu 3+ excitation window, unlike with quantum dots where the broad absorption windows of QDs overlap with that of many biochemical stains [47, 48] .
To validate the feasibility of luminescent NPs as droplet trackers, a mixed population of live and dead MDA-MB-231 doped NaYF 4 NPs at 37°C for 4 h (top row) and 12 h (bottom row) followed by live/dead staining using Calcein AM (green, middle column) and EthD-1 (red, right column). Scale bar is 300 μm cells was stained with EthD-1 and co-encapsulated with Eu 3+ -doped NPs in the microfluidic device (Fig. 5b) . The microfluidic trapping array was easily able to compartmentalize single MDA-MB-231 cells and NPs within droplets, thus enabling clear tracking of single cells based on their viability. The concentration of EthD-1 played a key role in obtaining a spectrally independent signal from the dead cells, with 2 μM identified as the optimal concentration due to a slight spectral bleed-through observed due to broad excitation window of the EthD-1 at higher concentrations. The results observed with Tb 3+ -doped NPs are shown in Fig. S3 (see ESM) . Although the selected Tb 3+ peak (centered at 543 nm) fell within the emission range of FITC filter collecting the GFP signal (λ em = 497-557 nm), no NP signal was detected from the FITC filter due to its higher excitation window. Additionally, no overlap was observed between Tb 3+ -doped NPs and RFP or EthD-1-stained cells due to their non-interfering ranges of emission Fig. S3 ). Further, it was observed that the Eu 3+ -and Tb
3+
-doped NPs were only detected in their respective filter sets. This highlights their potential to simultaneously track cells with two input conditions on a multiplexed microfluidic trapping array platform which is outside the scope of this paper.
Quantification of spectral independence between fluorescent stains and RE-doped NPs
All droplet generation experiments yielded a~99% droplet trapping efficiency with each NP-encapsulation experiment (Fig. 4) , resulting in~98% of the droplets containing NPs and~2% empty droplets. The fluorescent microscopy images from all cell/NP co-encapsulation experiments were processed and analyzed manually to categorize four different droplet subpopulations: (1) droplets with NP aggregates, (2) droplets with cells, (3) droplets with NP and cells, and (4) empty droplets. Single-cell encapsulation efficiencies from cases 2 and 3 followed a Poisson distribution as previously described [49] . An example analysis from three GFP-expressing HeLa and Eu
3+
-doped NP co-encapsulation experiments (n = 787 droplets from each experiment) yielded an average of 28 ± 1 (4%) empty droplets, 310 ± 36 (43%) droplets with NPs, 356 ± 37 (50%) droplets with NPs and cells, and 21 ± 7 (3%) droplets with cells (Fig. 6) . A similar distribution was observed for all cell/NP co-encapsulation experiments, subjected to no deviations from the specified cell density and NP concentration values. Until now, all the above-reported results have been qualitatively evaluated by visual inspection of the cells and NPs within the aqueous droplets. In effort to confirm that the signals observed were distinct and reproducible, the fluorescent and luminescent signals of the cells and NPs from their respective filter sets were measured across each of the droplet diameter. Results from GFP-HeLa/Eu 3+ -doped NP coencapsulation and RFP-MDA-MB-231/Eu 3+ -doped NP coencapsulation experiments are shown in Fig. 7a, b . Figure 7a -i represents a droplet with only a GFP-HeLa cell, where the cell gave a distinct signal in the FITC filter. Here, no signal was detected from the filter set 1 due to the absence of Eu 3+ -doped NPs. In Fig. 7a -ii, a droplet with single GFPHeLa cell co-encapsulated with Eu 3+ -doped NPs is shown. The cells and NPs exhibited distinct emission spectra contributing to clearly defined and distinct signals from their respective filter sets. Similarly, for an RFP-MDA-MB-231/Eu 3+ coencapsulation experiment, the cells and NPs gave distinct signals from their respective filter sets as shown in Fig. 7b (RFP from rhodamine filter and Eu 3+ NPs from filter set 1). Next, a population of live and dead MDA-MB-231 cells was stained with EthD-1 and co-encapsulated with Eu 3+ -doped NP inside droplets. The outcome of this experiment was categorized into six droplet subpopulations: droplets with (1) only NPs, (2) only live cell(s), (3) only dead cell(s), (4) live cell(s) with NPs, (5) dead cell(s) with NPs, and (6) a combination of live and dead cells with NPs co-encapsulated inside the same droplet. Example cases from subpopulations (4) and (5) are shown in Fig. 7c . In the case of co-encapsulating a live cell and NPs (Fig. 7c-i) , the Eu 3+ NP gave a prominent signal from filter set 1 while the live cells did not contribute to any fluorescent signal in rhodamine filter due to the lack of EthD-1 uptake. Conversely for a droplet co-encapsulating a dead cell and NP, the dead cell (presence of EthD-1) and Eu 3+ -doped NP gave distinct signals in their respective filter sets (Fig. 7c-ii) . Similar analyses for spectral independence of Tb 3+ -doped -doped NPs, the NPs had a prominent average S:N ratio value of~5:1 only observable with filter set 1 (ESM Table S1 ). Similarly, the fluorescent cells recorded distinct average S:N ratio values from only their respective filter sets: GFP in FITC filter, RFP and EthD-1 in rhodamine filter. Similar numerical validation was done for the spectral independence of Tb 3+ -doped NPs (ESM Table S2 ). The Tb 3+ -doped NP had a distinct average S:N ratio value of~3:1 from only its filter set 2, while the fluorescent cells recorded distinct signals from only their filter sets. Moreover, the Eu 3+ -doped NPs could not be detected above the noise using filter set 2 and likewise for Tb 
Dose-response analysis of MDA-MB-231 cells to paclitaxel using luminescent NPs
Single-cell analysis techniques have been instrumental in identifying low-occurrence, drug-resistant subpopulation of cells. Microfluidic droplet trapping arrays can quantify the intracellular distribution of fluorescence across single cells and directly visualize cells to minimize the number of false positives which occur during flow cytometry studies. However, tracking the inputs into these devices has been limited by overlapping fluorophores used for droplet tracking and biological interrogation. Thus, upon numerical validation and statistical characterization of spectral properties of the two luminescent NPs, the capabilities of the microfluidic droplet tracking platform were evaluated for a real-time application quantifying the single-cell responses to different therapeutic doses. MDA-MB-231 cells were treated off-chip with three different doses of paclitaxel (PTX), a microtubule inhibitor, for three different incubation times (24 h, 48 h, or 72 h). The single-cell dose response was tracked in the device using three corresponding NPs (Eu 3+ -doped NP for 10 μM, Tb 3+ -doped NP for 50 μM, and undoped NP for 100 μM PTX) in the microfluidic droplet array. The experiments at each of the three incubation times were performed simultaneously on the fluorescent microscopy stage to demonstrate the ability of the luminescent materials to discretely track cell viability after drug treatment with three different doses over a period of 72 h. A representative image of droplet tracking from the 48 h time point is shown in Fig. S5 (see ESM) , where a heterogeneous response was observed in terms of live cells (colorless due to the absence of EthD-1 uptake) and dead cells (red due to EthD-1 uptake) as tracked by Eu 3+ -doped NP for 10 μM PTX (ESM Fig. S5A ), Tb 3+ -doped NP for 50 μM PTX (ESM Fig. S5B ), and undoped NP for 100 μM (ESM Fig. S5C ). To determine if the results from these tracking experiments conformed with previously studied drug effects on MDA-MB-231 cells, the resultant heterogeneous dose-dependent cellular responses from duplicate droplet tracking-drug experiments were compared with no-drug positive control experiments. Figure 8 cells to PTX. Cells were treated with 10 μM, 50 μM, and 100 μM PTX off-chip and observed on-chip at 24 h, 48 h, and 72 h using droplet microfluidic tracking system. Significant differences compared to nodrug positive control treatment. *p < 0.1, **p < 0.05, ***p < 0.01 are indicated 27 cells (45.01%) to 32 ± 6 viable cells out of 124 ± 8 cells (21.63%) for the undoped NP-tracked 100 μM PTX during 24 to 72 h. Alternatively, healthy cell viability average of around 85% was observed throughout for the no-drug control population. The three different dose responses were statistically compared with the positive control with a null hypothesis being the average difference of cell viability between dosedependent responses and control is zero. After a series of onetailed t test (with α = 0.05), the null hypothesis was rejected in all cases based on the significant p values as shown in Fig. 8 . The findings from these droplet tracking studies were similar to previously reported drug studies [50] . These findings demonstrate the potential of luminescent nanomaterials coupled with a microfluidic droplet trapping array as an approach to provide insight on therapeutic effectiveness and dosedependent heterogeneous single-cell response at the same time. While the studies presented here were limited by a single-input microfluidic droplet trapping, the luminescent nanomaterials characterized here can be incorporated into multiple input droplet microfluidic devices [51] [52] [53] to exploit their full potential to track droplets, the results of which will be reported in the future. Nevertheless, the successful results from the single-input droplet tracking experiments emphasize the capability of expanding this in multiplicity by combining multi-inputs and similarly doped NPs to simultaneously track different input conditions at the same time.
Conclusions
A series of droplet tracking experiments co-encapsulating RE (Eu  3+ and Tb   3+ )-doped NPs and fluorescently labeled cells was successfully performed using a single-input microfluidic device. This platform utilized low-cost luminescent RE-doped NPs in a droplet microfluidic device instead of expensive, overlapping barcodes (antibodies and dyes) to demonstrate, for the first time, their ability to track droplets in a spectrally independent manner using fluorescent microscopy. This work found that the DC emission spectra of Eu 3+ -doped NP (in red) and Tb
3+
-doped NP (in green) did not overlap with common fluorophores (GFP, RFP) and fluorescent biochemical stain (EthD-1), thus overcoming the limitations of commonly used tracking materials. The fluorescence and luminescence signals of cells and NPs were quantified for spectral independence through a series of signal measurements and statistical single/two-tailed hypotheses tests. As a result of this robust quantification, the spectral independence of these RE-doped NPs was well ascertained. Furthermore, these biocompatible and spectrally independent RE-doped luminescent NPs were used to quantify single-cell dose response of MDA-MB-231 cells to PTX, where each of the NPs was able to visually isolate and distinctly track single cancer cells challenged with specific doses of drug. The strength of this tracking system to perform both population-based and single-cell analyses of cancer cells to identify distinct subpopulations of cells, including drug-resistant ones, was highlighted. While the data presented in this paper utilized only two RE dopants in a singleinput microfluidic droplet trapping array, this novel nanoparticle-microfluidic hybrid platform has significant potential for multiplexing to increase the number of parameters which are simultaneously screened and trapped for an improved statistical response. Additionally, this hybrid platform poses a clear advantage to perform multiplexed, dynamic cellular measurements including the intracellular distribution of biochemical stains.
